Stockscreener 앱 받기
76.91
3.19%
2.38
시장 영업 전:
77.48
0.57
+0.74%
전일 마감가:
$74.53
열려 있는:
$75.42
하루 거래량:
7.37M
Relative Volume:
1.06
시가총액:
$32.24B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
12.74
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
+2.44%
1개월 성능:
-3.05%
6개월 성능:
-38.30%
1년 성능:
-49.25%
1일 변동 폭
$75.39
$77.43
1주일 범위
$73.38
$77.43
52주 변동 폭
$71.47
$160.48
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
76.91 | 32.24B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
16.73 | 53.43B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.11 | 44.52B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.22 | 37.52B | 17.53B | 1.58B | 444.18M | 1.3457 |
UTHR
United Therapeutics Corp
|
529.05 | 22.46B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Bleakley Financial Group LLC Acquires New Position in Zoetis Inc. $ZTS - MarketBeat
Aware Super Pty Ltd as trustee of Aware Super Acquires Shares of 250,920 Zoetis Inc. $ZTS - MarketBeat
Bank of New York Mellon Corp Reduces Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis-Neogen Genomics deal referred to in-depth review in Australia - MLex
Daily Brief Health Care: First Wave BioPharma , NeuroSpectrum Insights, Mesoblast Ltd, Know Labs , Zoetis Inc, CTT Pharmaceutical Holdings, Oncolytics Biotech, ATAI Life Sciences NV and more - Smartkarma
Zoetis Inc (ZTS) Stock Up 3.2% and Still Undervalued -- GF Score: 76/100 - GuruFocus
Zoetis Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS - GlobeNewswire Inc.
Byron Donalds of Florida’s 19th District adjusts portfolio, trading in Cadence, Monolithic and Zoetis stocks - Investing.com
Zoetis Gains as VitalRADS Deal Boosts Diagnostics Narrative - Quiver Quantitative
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of July 27, 2026 in Zoetis Inc. LawsuitZTS - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming DeadlinesZTS - PR Newswire
ZOETIS INC. (ZTS) SHAREHOLDER ALERT Bernstein Liebhard LLP - GlobeNewswire
Zoetis to acquire VitalRADS to expand veterinary diagnostics platform - ROI-NJ
Zoetis Earnings Preview: What to Expect - Yahoo Finance
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Zoetis to acquire vet teleradiology services firm VitalRads - pehub.com
Zoetis Deadline: ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit - The Conway Daily Sun
Kaplan Fox & Kilsheimer LLP Alerts Zoetis Inc. (NYSE: ZTS) Investors to a Securities Class Action Deadline on July 27, 2026 - NewMediaWire
Kaplan Fox & Kilsheimer LLP Alerts Zoetis Inc. (NYSE: ZTS) Invest - The National Law Review
Here's What We Like About Zoetis' (NYSE:ZTS) Upcoming Dividend - simplywall.st
Levi & Korsinsky Reminds Zoetis Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 27, 2026ZTS - PR Newswire
Zoetis launches Lenivia for dog osteoarthritis pain in Canada, EU - Investing.com
Zoetis Launches Lenivia for Osteoarthritis Pain Management (ZTS) - GuruFocus
Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union - Business Wire
Zoetis Acquired VitalRads. Here’s What That Means For Your Practice - Vet Candy
Labaton Keller Sucharow LLP Files Securities Class Action Against Zoetis, Inc. and Certain of Its Executives - AOL.com
J. Safra Sarasin Holding AG Trims Stake in Zoetis Inc. $ZTS - MarketBeat
Fifth Third Bancorp Purchases 68,180 Shares of Zoetis Inc. $ZTS - MarketBeat
Form 4 Zoetis Inc For: 14 July By Investing.com - Investing.com Nigeria
Zoetis To Acquire VitalRADS To Expand Veterinary Diagnostic Capabilities - Pulse 2.0
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Zoetis (NYSE: ZTS) CEO awarded cash-settled phantom units - Stock Titan
Zoetis Inc. (NYSE: ZTS) awards 259 phantom stock units to its EVP - Stock Titan
Zoetis (ZTS) EVP Kevin Esch receives cash-settled phantom stock grant - Stock Titan
Zoetis Inc. (NYSE: ZTS) EVP awarded 237.6361 phantom units - Stock Titan
Zoetis Inc. (NYSE: ZTS) grants EVP 314.6453 phantom stock units - Stock Titan
Zoetis (NYSE: ZTS) EVP gains phantom stock units in savings plan - Stock Titan
Zoetis (NYSE: ZTS) EVP receives cash-settled phantom stock unit award - Stock Titan
Zoetis Inc. (NYSE: ZTS) CFO awarded cash-settled phantom units - Stock Titan
Zoetis Inc. (NYSE: ZTS) EVP updates phantom stock unit balance - Stock Titan
Class action lawsuit filed against Zoetis over alleged securities fraud after profit guidance cut. - Pluang
ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsu - GuruFocus
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zoetis Announces Agreement to Acquire VitalRADS, Accelerating Diagnostic Capabilities - BioSpace
Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost - GlobeNewswire
Zoetis (ZTS) Expands Diagnostic Services with VitalRADS Acquisition - GuruFocus
ZTS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zoetis Inc. Securities Lawsuit - GlobeNewswire Inc.
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.09%
0.52%
자본화:
|
볼륨(24시간):